CASE REPORT
Published on 04 Jun 2025
Treatment strategies for rapid recurrence and progression after surgery for stage I pulmonary pleomorphic carcinoma: a case report and literature review
doi 10.3389/fimmu.2025.1547872
- 287 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Advancing NSCLC Treatment: Overcoming Challenges in Immune Checkpoint Inhibitor Therapy
Advancing NSCLC Treatment: Overcoming Challenges in Immune Checkpoint Inhibitor Therapy
3,445
Total downloads
16k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 04 Jun 2025
First-line treatment options for PD-L1-negative lung adenocarcinoma: a real-world analysis
doi 10.3389/fonc.2025.1533048
- 224 views
ORIGINAL RESEARCH
Accepted on 30 May 2025
Prognostic Analysis and Association of the Systemic Immune-Inflammatory Index with Immune Checkpoint Inhibitor Pneumonitis in Patients with Non-Small Cell Lung Cancer
doi 10.3389/fonc.2025.1596223
- 110 views
ORIGINAL RESEARCH
Accepted on 26 May 2025
Induction chemoimmunotherapy may achieve non-inferior outcomes to consolidation immunotherapy in patients with unresectable stage III NSCLC: a real-world multicenter retrospective study
doi 10.3389/fimmu.2025.1591134
- 193 views
CASE REPORT
Published on 30 Apr 2025
Acquired ROS1 fusion and iruplinalkib response in advanced NSCLC after multiple lines of systematic therapy: a case report
doi 10.3389/fonc.2025.1571512
- 804 views
SYSTEMATIC REVIEW
Published on 08 Apr 2025
Adjuvant immunotherapy improves survival in completely resected stage IB–III NSCLC: a systematic review and meta-analysis
doi 10.3389/fonc.2025.1493221
- 1,256 views
ORIGINAL RESEARCH
Published on 03 Apr 2025
From COPD to cancer: indacaterol’s unexpected role in combating NSCLC
doi 10.3389/fphar.2025.1579126
- 859 views
MINI REVIEW
Published on 21 Mar 2025
The distinct roles of IL-37 and IL-38 in non-small cell lung carcinoma and their clinical implications
doi 10.3389/fimmu.2025.1564357
- 1,555 views
METHODS
Published on 17 Mar 2025
Association between CONUT scores and survival outcomes in patients with non-small cell lung cancer: meta-analysis from 4973 Asian cases
doi 10.3389/fonc.2025.1522368
- 621 views
CASE REPORT
Published on 06 Mar 2025
Tislelizumab-induced type 1 diabetic ketoacidosis in a patient with small cell lung cancer: a case report
doi 10.3389/fonc.2025.1498701
- 941 views
- 1 citation
ORIGINAL RESEARCH
Published on 20 Feb 2025
Real-world treatment and retreatment patterns and outcomes in patients with advanced or metastatic non-small cell lung cancer following nivolumab monotherapy in second line or later in France: an I-O Optimise analysis
doi 10.3389/fonc.2025.1526931
- 2,170 views
CASE REPORT
Published on 23 Jan 2025
Pulmonary enteric adenocarcinoma with progression disease after second - line therapy: a case report
doi 10.3389/fonc.2025.1509026
- 800 views
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Immunology
- 5.7 impact factor
- 9.8 citescore
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore